Inhibitory effect of the human liver-derived antimicrobial peptide hepcidin 20 on biofilms of polysaccharide intercellular adhesin (PIA)-positive and PIA-negative strains of Staphylococcus epidermidis

Biofouling

Volumn 30, Issue 4, 2014, Pages 435-446

  Brancatisano, Franca Lisa ^a   Maisetta, Giuseppantonio ^a   Di Luca, Mariagrazia ^a,b   Esin, Semih ^a   Bottai, Daria ^a   Bizzarri, Ranieri ^b   Campa, Mario ^a   Batoni, Giovanna ^a  

^a UNIVERSITY OF PISA   (Italy)

^b ISTITUTO NANOSCIENZE CNR   (Italy)

Author keywords

antimicrobial peptides; biofilm; extracellular matrix; hepcidin 20; polysaccharide intercellular adhesin; Staphylococcus epidermidis

Indexed keywords

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS EPIDERMIDIS;

ANTIINFECTIVE AGENT; BACTERIAL POLYSACCHARIDE; HEPCIDIN; HEPCIDIN (6-25), HUMAN; PEPTIDE FRAGMENT; POLYSACCHARIDE INTERCELLULAR ADHESIN; VANCOMYCIN;

BIOFILM; CONFOCAL MICROSCOPY; DRUG EFFECTS; GENETICS; HUMAN; PH; PHYSIOLOGY; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-INFECTIVE AGENTS; BIOFILMS; HEPCIDINS; HUMANS; HYDROGEN-ION CONCENTRATION; MICROSCOPY, CONFOCAL; PEPTIDE FRAGMENTS; POLYSACCHARIDES, BACTERIAL; STAPHYLOCOCCUS EPIDERMIDIS; VANCOMYCIN;

EID: 84898541314     PISSN: 08927014     EISSN: 10292454     Source Type: Journal    
DOI: 10.1080/08927014.2014.888062     Document Type: Article

References (24)

1. Arciola CR, Campoccia D, Gamberini S, Donati ME, Pirini V, Visai L, Speziale P, Montanaro L. 2005. Antibiotic resistance in exopolysaccharide-forming Staphylococcus epidermidis clinical isolates from orthopaedic implant infections. Biomaterials. 26:6530-6535.
2. Batoni G, Maisetta G, Brancatisano FL, Esin S, Campa M. 2011. Use of antimicrobial peptides against microbial biofilms: advantages and limits. Curr Med Chem. 18:256-279.
3. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 15:167-193.
4. Fey PD, Olson ME. 2010. Current concepts in biofilm formation of Staphylococcus epidermidis. Future Microbiol. 5:917-933.
5. Flemming HC, Wingender J. 2010. The biofilm matrix. Nat Rev Microbiol. 8:623-633.
6. Freeman DJ, Falkiner FR, Keane CT. 1989. New method for detecting slime production by coagulase negative staphylococci. J Clin Pathol. 42:872-874.
7. Ganz T, Nemeth E. 2012. Hepcidin and iron homeostasis. Biochim Biophys Acta. 1823:1434-1443.
8. Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. 2010. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 35:322-332.
9. Jefferson KK, Goldmann DA, Pier GB. 2005. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob Agents Ch. 49:2467-2473.
10. Kogan G, Sadovskaya I, Chaignon P, Chokr A, Jabbouri S. 2006. Biofilms of clinical strains of Staphylococcus that do not contain polysaccharide intercellular adhesin. FEMS Microbiol Lett. 255:11-16.
11. Mack D, Haeder M, Siemssen N, Laufs R. 1996. Association of biofilm production of coagulase-negative staphylococci with expression of a specific polysaccharide intercellular adhesin. J Infect Dis. 174:881-884.
12. Maisetta G, Petruzzelli R, Brancatisano FL, Esin S, Vitali A, Campa M, Batoni G. 2010. Antimicrobial activity of human hepcidin 20 and 25 against clinically relevant bacterial strains: effect of copper and acidic pH. Peptides. 31:1995-2002.
13. Maisetta G, Vitali A, Scorciapino MA, Rinaldi AC, Petruzzelli R, Brancatisano FL, Esin S, Stringaro A, Colone M, Luzi C, et al. 2013. pH-dependent disruption of Escherichia coli ATCC25922 and model membranes by the human antimicrobial peptides hepcidin 20 and 25. FEBS J. 280:2842-2854.
14. Monzón M, Oteiza C, Leiva J, Lamata M, Amorena B. 2002. Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diagn Microbiol Infect Dis. 44:319-324.
15. Nagant C, Pitts B, Nazmi K, Vandenbranden M, Bolscher JG, Stewart PS, Dehaye JP. 2012. Identification of peptides derived from the human antimicrobial peptide LL-37 active against biofilms formed by Pseudomonas aeruginosa using a library of truncated fragments. Antimicrob Agents Ch. 56:5698-5708.
16. Nemeth E, Preza GC, Jung CL, Kaplan J, Waring AJ, Ganz T. 2006. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood. 107:328-333.
17. Otto M. 2009. Staphylococcus epidermidis-the 'accidental' pathogen. Nat Rev Microbiol. 7:555-567.
18. Pettit RK, Weber CA, Kean MJ, Hoffmann H, Pettit GR, Tan R, Franks KS, Horton ML. 2005. Microplate alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Ch. 49:2612-2617.
19. Rohde H, Burandt EC, Siemssen N, Frommelt L, Burdelski C, Wurster S, Scherpe S, Davies AP, Harris LG, Horstkotte MA, et al. 2007. Polysaccharide intercellular adhesin or protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials. 28:1711-1720.
20. Schibli DJ, Hunter HN, Aseyev V, Starner TD, Wiencek JM, McCray Jr. PB, Tack BF, Vogel HJ. 2002. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J Biol Chem. 277:8279-8289.
21. Stepanović S, Vuković D, Hola V, Di Bonaventura G, Djukić S, Cirković I, Ruzicka F. 2007. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 115:891-899.
22. Tavanti A, Maisetta G, Del Gaudio G, Petruzzelli R, Sanguinetti M, Batoni G, Senesi S. 2011. Fungicidal activity of the human peptide hepcidin 20 alone or in combination with other antifungals against Candida glabrata isolates. Peptides. 32:2484-2487.
23. Zhu C, Tan H, Cheng T, Shen H, Shao J, Guo Y, Shi S, Zhang X. 2013. Human β-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation. J Surg Res. 183:204-213.
24. Ziebuhr W, Krimmer V, Rachid S, Lössner I, Götz F, Hacker J. 1999. A novel mechanism of phase variation of virulence in Staphylococcus epidermidis: evidence for control of the polysaccharide intercellular adhesin synthesis by alternating insertion and excision of the insertion sequence element IS256. Mol Microbiol. 32:345-356.